Series A funding round for Superluminal Medicines raising $120M in September 2024
Series A funding round for Superluminal Medicines raising $120M in September 2024
| Investor | Firm Type | Partner |
|---|
| Private | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Angel | Jeremy Yap |
This company has completed 2 funding rounds. Current round is highlighted.
Total Raised
$153M
Top Valuation
-
Superluminal Medicines raised $120M in a Series A round.
The round was announced on 09/01/24.
The round was led by RA Capital Management.